
KALA BIO Investor Relations Material
Latest events

Q2 2022
KALA BIO
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from KALA BIO Inc
Access all reports
KALA BIO Inc. (formerly Kala Pharmaceuticals Inc.) is a biopharmaceutical company focused on developing and commercializing innovative treatments for ocular diseases. The company leverages its proprietary AMPPLIFY drug delivery technology, which enhances the penetration of therapeutic agents into target tissues. KALA BIO’s product portfolio includes treatments for conditions such as dry eye disease, ocular inflammation, and other front-of-the-eye disorders. The company is headquartered in Arlington, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
KALA
Country
🇺🇸 United States